samedan logo
home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.

For further information please contact:

Simon Caplan

Will Brown

We're also on Twitter! Follow us @PMPSmag   


Click here to view the digital version of PMPS




Click here to view the digital version






Click here to view the digital version


Featured in this issue
Robotics, AI, and Software
Eight Key Benefits to Automation for Pharma Manufacturing

Kenny Watson at Linde Material Handling UK

Automating processes can offer substantial improvements for pharmaceutical companies looking to cut costs, improve efficiency, and build a more intuitive system fit for the future
Robotics, AI, and Software
The Prescription for Pharma’s Digital Future

Andrew Borland at University of Liverpool’s VEC

Industry 4.0, AI, and automation are forging a new path for the pharmaceutical industry, encouraging further development for companies looking to move into this area
  Cold Chain Challenges
Maintaining Cold Chain Integrity for Pharmaceutical Products

Muge Suner at Thermo King EMEA

While the ultra-low temperature distribution of vaccines has taken the headlines, there has been a tireless effort to keep the cold chain functioning through once-in-a-generation demand


Published quarterly in
February, May,
August, and November


News and Press Releases


OXFORD, England, 22nd September - Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd. has launched its new Aidaptus® auto-injector platform following successful completion of development.
More info >>

White Papers

Crossing the Blood Brain Barrier (BBB): Which Route to Take?

Aptar Pharma

Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement